Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Is the CTSO "XL" product still going to eliminate PMX need?
View:
Post by SouthernTierTom on Mar 16, 2022 2:06pm

Is the CTSO "XL" product still going to eliminate PMX need?

Comment by SouthernTierTom on Mar 16, 2022 2:06pm
In a head-to-head comparison with the leading endotoxin adsorber, Toraymyxin™ (Toray, Japan), CytoSorb-XL matched the level of endotoxin reduction in an in vitro plasma recirculation system on a comparable volume basis.  CytoSorb-XL is expected to eliminate the need for stand-alone endotoxin specific filters by offering superior performance in the removal of not just endotoxin, ...more  
Comment by mercedesman on Mar 16, 2022 2:19pm
One would think it was twice as absorbant , given that CTSO's market cap is still about twice that of Spectral's. Maybe they re just twice as far along the way to FDA approval? MM
Comment by SouthernTierTom on Mar 16, 2022 2:40pm
BOLD statement ... AND "unchallenged" Tell me, mirror mirror on the wall ... "has the XL ever been used on a human at all"? And the detail promptly delivered by our good friend the "economist" at an AGM .... "Indeed Doc, John is our friend"....but ultimately a BIG FAN of PMX and now a shareholder near as LARGE as you!  Free dessert for ALL those on ...more  
Comment by mercedesman on Mar 16, 2022 2:52pm
Maybe they never tested the XL on humans cuz it was just too risky to eliminate other inflammatory mediators ?  I heard some of those sight-o-kinds is good for you...so is it a good idea to take them fellers away threw philtration ? Not so with those ender-tocks-ins.  They's just nasty.   Even for those poor Covid getters in hospital. A million of them died ya know. MM
Comment by PezDalatoYou on Mar 17, 2022 10:29am
What a strange thing to highlight and post on the EDT board. Either Tom got his boards (or aliases) mixed up again or he's CTSO's newest big shareholder. So weird.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities